Neuroleptic Malignant Syndrome (NMS) is a rare but potentially life-threatening reaction to antipsychotic medications. Recognizing its symptoms and understanding its management is crucial for psychiatrists. The Journal of Clinical Psychiatry provides in-depth insights into NMS, from its pathophysiology to evidence-based treatment approaches. Our expert editors ensure that content is both clinically relevant and actionable, aiding psychiatrists in the timely diagnosis and management of this critical condition.
Neuroleptic Malignant Syndrome
Recently published articles about Neuroleptic Malignant Syndrome
Case Report
Rapidly Reversed Symptoms Consistent With Neuroleptic Malignant Syndrome
June 10, 2021
When there is suspicion for neuroleptic malignant syndrome, prompt medical therapy and discontinuation of the offending agent are crucial. This report presents an atypical case of this potentially fatal...
Letter to the Editor
Psoas Abscess as a Differential Diagnosis of Neuroleptic Malignant Syndrome
November 1, 2018
Diagnosis of NMS is complicated by coexisting pathologies that have a similar clinical picture. This report describes a woman with schizoaffective disorder who presented with a psychotic episode and...
